CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 405 of 865
Non-Antibody Products
Page 405 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| IOWH-032 | A modulator of CFTR; inhibits CFTR in T84 human colon cells (IC50 = 8.51 &… | 5 mg | 30273-5 | More Info |
| IOWH-032 | A modulator of CFTR; inhibits CFTR in T84 human colon cells (IC50 = 8.51 &… | 50 mg | 30273-50 | More Info |
| IOX1 | A broad-spectrum inhibitor of 2OG oxygenases that inhibits JMJD2 demethyla… | 10 mg | 11572-10 | More Info |
| IOX1 | A broad-spectrum inhibitor of 2OG oxygenases that inhibits JMJD2 demethyla… | 25 mg | 11572-25 | More Info |
| IOX1 | A broad-spectrum inhibitor of 2OG oxygenases that inhibits JMJD2 demethyla… | 5 mg | 11572-5 | More Info |
| IOX1 | A broad-spectrum inhibitor of 2OG oxygenases that inhibits JMJD2 demethyla… | 50 mg | 11572-50 | More Info |
| IOX2 | An inhibitor of HIF-PH2 (IC50 = 21 nM); potent, cell permeable inhibitor o… | 10 mg | 11573-10 | More Info |
| IOX2 | An inhibitor of HIF-PH2 (IC50 = 21 nM); potent, cell permeable inhibitor o… | 25 mg | 11573-25 | More Info |
| IOX2 | An inhibitor of HIF-PH2 (IC50 = 21 nM); potent, cell permeable inhibitor o… | 5 mg | 11573-5 | More Info |
| IOX2 | An inhibitor of HIF-PH2 (IC50 = 21 nM); potent, cell permeable inhibitor o… | 50 mg | 11573-50 | More Info |
| IOX4 | A selective, potent inhibitor of HIF-PH2 (IC50 = 1.6 nM); active in vivo,… | 10 mg | 18181-10 | More Info |
| IOX4 | A selective, potent inhibitor of HIF-PH2 (IC50 = 1.6 nM); active in vivo,… | 25 mg | 18181-25 | More Info |
| IOX4 | A selective, potent inhibitor of HIF-PH2 (IC50 = 1.6 nM); active in vivo,… | 5 mg | 18181-5 | More Info |
| IOX4 | A selective, potent inhibitor of HIF-PH2 (IC50 = 1.6 nM); active in vivo,… | 50 mg | 18181-50 | More Info |
| IPA-3 | An inhibitor of PAK1 activation (IC50 = 2.5 µM); does not inhibit pr… | 10 mg | 14759-10 | More Info |
| IPA-3 | An inhibitor of PAK1 activation (IC50 = 2.5 µM); does not inhibit pr… | 25 mg | 14759-25 | More Info |
| IPA-3 | An inhibitor of PAK1 activation (IC50 = 2.5 µM); does not inhibit pr… | 5 mg | 14759-5 | More Info |
| IPA-3 | An inhibitor of PAK1 activation (IC50 = 2.5 µM); does not inhibit pr… | 50 mg | 14759-50 | More Info |
| Ipamorelin (acetate) | A growth hormone secretagogue and GHS-R1a agonist; binds to COS-7 cells ex… | 10 mg | 39813-10 | More Info |
| Ipamorelin (acetate) | A growth hormone secretagogue and GHS-R1a agonist; binds to COS-7 cells ex… | 25 mg | 39813-25 | More Info |
| Ipamorelin (acetate) | A growth hormone secretagogue and GHS-R1a agonist; binds to COS-7 cells ex… | 5 mg | 39813-5 | More Info |
| IPBT-5CA | A selective agonist of GPR109B (HCA3; EC50 = 400 nM) that displays no acti… | 1 g | 15223-1 | More Info |
| IPBT-5CA | A selective agonist of GPR109B (HCA3; EC50 = 400 nM) that displays no acti… | 100 mg | 15223-100 | More Info |
| IPBT-5CA | A selective agonist of GPR109B (HCA3; EC50 = 400 nM) that displays no acti… | 50 mg | 15223-50 | More Info |
| IPBT-5CA | A selective agonist of GPR109B (HCA3; EC50 = 400 nM) that displays no acti… | 500 mg | 15223-500 | More Info |
| iPDMB-FUBINACA | An analytical reference standard that is structurally similar to known syn… | 1 mg | 28930-1 | More Info |
| iPDMB-FUBINACA | An analytical reference standard that is structurally similar to known syn… | 5 mg | 28930-5 | More Info |
| IP7e | An activator of Nurr1 signaling (EC50 = 3.9 nM in a reporter assay); preve… | 1 mg | 29726-1 | More Info |
| IP7e | An activator of Nurr1 signaling (EC50 = 3.9 nM in a reporter assay); preve… | 5 mg | 29726-5 | More Info |
| Iperoxo (iodide) | An agonist of muscarinic acetylcholine receptors; stimulates [35S]GTP&gamm… | 1 mg | 27235-1 | More Info |
| Iperoxo (iodide) | An agonist of muscarinic acetylcholine receptors; stimulates [35S]GTP&gamm… | 10 mg | 27235-10 | More Info |
| Iperoxo (iodide) | An agonist of muscarinic acetylcholine receptors; stimulates [35S]GTP&gamm… | 5 mg | 27235-5 | More Info |
| IPG-1 AM | A cell-permeable fluorescent potassium indicator; binds to potassium (Kd =… | 0.5 mg | 35542-1050 | More Info |
| IPG-1 AM | A cell-permeable fluorescent potassium indicator; binds to potassium (Kd =… | 500 µg | 35542-500 | More Info |
| IPG-2 AM | A cell-permeable fluorescent potassium indicator; binds to potassium (Kd =… | 0.5 mg | 35540-1050 | More Info |
| IPG-2 AM | A cell-permeable fluorescent potassium indicator; binds to potassium (Kd =… | 500 µg | 35540-500 | More Info |
| IPG-4 AM | A cell-permeable fluorescent potassium indicator; has been used to detect… | 0.5 mg | 35541-1050 | More Info |
| IPG-4 AM | A cell-permeable fluorescent potassium indicator; has been used to detect… | 500 µg | 35541-500 | More Info |
| IPG-1 TMA | A cell-impermeable fluorescent potassium indicator; binds to potassium (Kd… | 0.5 mg | 35543-1050 | More Info |
| IPG-1 TMA | A cell-impermeable fluorescent potassium indicator; binds to potassium (Kd… | 500 µg | 35543-500 | More Info |
| IPG-2 TMA | A cell-impermeable fluorescent potassium indicator; binds to potassium (Kd… | 0.5 mg | 35533-1050 | More Info |
| IPG-2 TMA | A cell-impermeable fluorescent potassium indicator; binds to potassium (Kd… | 500 µg | 35533-500 | More Info |
| IPG-4 TMA | A cell-impermeable fluorescent potassium indicator; has been used to detec… | 0.5 mg | 35539-1050 | More Info |
| IPG-4 TMA | A cell-impermeable fluorescent potassium indicator; has been used to detec… | 500 µg | 35539-500 | More Info |
| IPI-145 | A potent, selective, and orally bioavailable inhibitor of PI3Kγ and… | 1 mg | 16800-1 | More Info |
| IPI-145 | A potent, selective, and orally bioavailable inhibitor of PI3Kγ and… | 10 mg | 16800-10 | More Info |
| IPI-145 | A potent, selective, and orally bioavailable inhibitor of PI3Kγ and… | 5 mg | 16800-5 | More Info |
| IPI-145 | A potent, selective, and orally bioavailable inhibitor of PI3Kγ and… | 500 µg | 16800-500 | More Info |
| IPI-549 | An inhibitor of PI3Kγ (IC50s = 16, 3,200, 3,500, and >8,400 nM for P… | 1 mg | 26416-1 | More Info |
| IPI-549 | An inhibitor of PI3Kγ (IC50s = 16, 3,200, 3,500, and >8,400 nM for P… | 10 mg | 26416-10 | More Info |
| IPI-549 | An inhibitor of PI3Kγ (IC50s = 16, 3,200, 3,500, and >8,400 nM for P… | 25 mg | 26416-25 | More Info |
| IPI-549 | An inhibitor of PI3Kγ (IC50s = 16, 3,200, 3,500, and >8,400 nM for P… | 5 mg | 26416-5 | More Info |
| Ipidacrine | An AChE inhibitor; induces LTP in rat hippocampal slices at 10 µM; p… | 1 g | 34529-1 | More Info |
| Ipidacrine | An AChE inhibitor; induces LTP in rat hippocampal slices at 10 µM; p… | 5 g | 34529-5 | More Info |
| Ipidacrine | An AChE inhibitor; induces LTP in rat hippocampal slices at 10 µM; p… | 500 mg | 34529-500 | More Info |
| IPN60090 | A GLS1 inhibitor (IC50 = 0.031 µM for the glutaminase C isoform); se… | 1 mg | 35855-1 | More Info |
| IPN60090 | A GLS1 inhibitor (IC50 = 0.031 µM for the glutaminase C isoform); se… | 5 mg | 35855-5 | More Info |
| 25iP-NBOMe (hydrochloride) | A phenethylamine whose physiological and toxicological properties have not… | 1 mg | 18170-1 | More Info |
| 25iP-NBOMe (hydrochloride) | A phenethylamine whose physiological and toxicological properties have not… | 5 mg | 18170-5 | More Info |
| 25iP-NBOMe (hydrochloride) | A phenethylamine whose physiological and toxicological properties have not… | 50 mg | 18170-50 | More Info |
| 4-IPP | A MIF inhibitor; a suicide substrate for MIF; inhibits the migration and a… | 10 mg | 31770-10 | More Info |
| 4-IPP | A MIF inhibitor; a suicide substrate for MIF; inhibits the migration and a… | 25 mg | 31770-25 | More Info |
| 4-IPP | A MIF inhibitor; a suicide substrate for MIF; inhibits the migration and a… | 5 mg | 31770-5 | More Info |
| 4-IPP | A MIF inhibitor; a suicide substrate for MIF; inhibits the migration and a… | 50 mg | 31770-50 | More Info |
| Ipragliflozin | A SGLT2 inhibitor (IC50 = 7.4 nM in CHO cells expressing the human cotrans… | 10 mg | 22287-10 | More Info |
| Ipragliflozin | A SGLT2 inhibitor (IC50 = 7.4 nM in CHO cells expressing the human cotrans… | 100 mg | 22287-100 | More Info |
| Ipragliflozin | A SGLT2 inhibitor (IC50 = 7.4 nM in CHO cells expressing the human cotrans… | 250 mg | 22287-250 | More Info |
| Ipragliflozin | A SGLT2 inhibitor (IC50 = 7.4 nM in CHO cells expressing the human cotrans… | 50 mg | 22287-50 | More Info |
| Ipragliflozin-13C6 | An internal standard for the quantification of ipragliflozin by GC- or LC-… | 1 mg | 28705-1 | More Info |
| Ipragliflozin-13C6 | An internal standard for the quantification of ipragliflozin by GC- or LC-… | 500 µg | 28705-500 | More Info |
| Ipratropium (bromide) | A muscarinic receptor antagonist (IC50s = 2.9, 2, and 1.7 nM for M1, M2, a… | 100 mg | 29423-100 | More Info |
| Ipratropium (bromide) | A muscarinic receptor antagonist (IC50s = 2.9, 2, and 1.7 nM for M1, M2, a… | 25 mg | 29423-25 | More Info |
| Ipratropium (bromide) | A muscarinic receptor antagonist (IC50s = 2.9, 2, and 1.7 nM for M1, M2, a… | 50 mg | 29423-50 | More Info |
| IP Receptor (human) Blocking Peptide | Peptide Sequence: human IP receptor amino acids · To be used in con… | 1 ea | 10005519-200 | More Info |
| IP Receptor (mouse) Blocking Peptide | Peptide Sequence: human IP receptor amino acids · To be used in con… | 1 ea | 360070-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile